Nicotinamide Mononucleotide (NMN) Market Size, Share, Growth, And Industry Analysis By Type (Content below 98% and Content above 98%) By Application (Health Care Products, Cosmetics, and Others), Regional Insights, and Forecast To 2033

Last Updated: 21 July 2025
SKU ID: 21051587

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET OVERVIEW

The global nicotinamide mononucleotide (nmn) market was valued at USD 0.33 billion in 2024 and is expected to grow to USD 0.36 billion in 2025, reaching USD 0.79 billion by 2033, with a projected CAGR of 10% during the forecast period.

Our bodies naturally contain nicotinamide mononucleotide (NMN), essential for cellular health and energy metabolism. NMN has drawn much interest recently due to its possible anti-aging benefits and capacity to enhance general health and fitness. As a result, several businesses have created and sold various NMN supplements, leading to a considerable increase in the nicotinamide mononucleotide (NMN) market. Oral capsules or tablets are among the most often used NMN supplements. These supplements come in various strengths and quantities and are simple to consume. Sublingual pills, positioned beneath the tongue and absorbed immediately into circulation for quicker benefits, are another well-liked type of NMN. Several businesses also sell NMN in powder form, which is simple to consume when combined with water or other liquids.

Together with these conventional supplements, more recent NMN products are available on the market, such as transdermal patches and nasal sprays. These different distribution techniques have advantages and can work better for some people. The finest NMN supplement will ultimately rely on your unique demands and preferences. Overall, the market for nicotinamide mononucleotide (NMN) is expanding quickly as more individuals become interested in the strong substance’s possible health advantages. With so many kinds of NMN supplements on the market, it’s crucial to conduct your homework and pick a reliable company that sells top-notch goods.

NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET KEY FINDINGS

  • Market Size and Growth: Valued at USD 0.33 billion in 2024, expected to reach USD 0.79 billion by 2033, growing at a CAGR 10%
  • Key Market Driver: NMN usage in wellness products rose by 47%, driven notably by rising consumer interest in health‑maintenance and anti‑aging benefits globally.
  • Major Market Restraint: Active ingredient levels in commercial NMN supplements deviated from labels by +28.6% to -100%, highlighting ongoing significant quality control challenges. 
  • Emerging Trends: Online NMN sales rose by 52%, positioning e‑commerce rapidly as the dominant distribution channel in the global market landscape across regions. 
  • Regional Leadership: North America consistently commands over 40% of global NMN market share, maintaining its position as the leading dominant regional market.
  • Competitive Landscape: Top three NMN vendors accounted for approximately 74.43% of total market revenue in 2023, reflecting a highly concentrated competitive landscape.
  • Market Segmentation: High‑purity (≥98%) NMN products comprised 64% of global offerings in 2023, while lower‑purity (<98%) products represented 36% of the market.
  • Recent Development: Over 600 new NMN products launched in 2023, marking a notably significant 28% year‑on‑year annual increase in product introductions worldwide.

COVID-19 IMPACT

 Rapid Spread Of The Virus Over The Globe Accelerated The Market Growth

The COVID-19 pandemic has significantly impacted the market for Nicotinamide Mononucleotide (NMN). The need for health supplements has increased dramatically as the globe struggles to contain the epidemic. Demand for NMN, which has anti-aging and anti-inflammatory qualities, has increased as more individuals want to strengthen their immune systems and maintain good health. The epidemic has, however, also hampered the supply system, causing shortages and price increases. Despite these obstacles, the NMN market is anticipated to continue developing due to increased demand for natural health supplements and growing awareness of their advantages. NMN is positioned to be increasingly significant in promoting health and wellness as the globe struggles to contain the epidemic.

LATEST TRENDS

Increasing Availability Of High-Quality Supplements From Reputable Manufacturers Boost the Market Expansion

There is definitely cause for excitement over the most recent trend in the nicotinamide mononucleotides (NMN) market! The demand for this supplement has surged as more and more individuals become aware of the possible health advantages of NMN. Given that NMN has been demonstrated to have anti-aging qualities, increase energy levels, and even enhance cognitive function, it comes as no surprise. The expanding availability of top-notch supplements from reliable suppliers is one of the most significant trends in the NMN industry. Users of these supplements may be sure they’re receiving the most strong and most effective supplement because it’s frequently prepared with pure, pharmaceutical-grade NMN. The use of NMN in conjunction with other dietary supplements or substances, such as resveratrol or metformin, is another approach that is gaining popularity. This strategy is predicated on the notion that these compounds complement each other to increase the advantages of NMN. Overall, the current market trends for Nicotinamide Mononucleotide (NMN) are evidence of the rising demand for this potent dietary supplement. We may anticipate even more interesting advancements in the future as more research is undertaken and more individuals benefit from NMN directly.

  • Over 600 new NMN products launched in 2023, marking a 28% year‑on‑year rise in global product availability—capsules remain dominant, accounting for 74% of deliveries, while high‑purity forms (≥98%) reached 64% of market share
  • E‑commerce drives 82% of NMN sales, with online subscriptions up by 19% in 2023, reflecting the shift to digital-first health purchasing .

NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET SEGMENTATION

By Type Analysis

The nicotinamide mononucleotide (NMN) market can be segmented into the content below 98% and content above 98%. Among these, content below 98% is projected to experience rapid growth through forecast period.

By Application Analysis

The market can be divided based on application into health care products, cosmetics, and others. Health care products are expected to hold the most significant nicotinamide mononucleotide (NMN) market share in the upcoming years.

DRIVING FACTORS

Growing Demand For Anti-Aging Supplements And Treatments Propels the Market Expansion

The market for nicotinamide mononucleotides (NMN) is expanding and rising quickly, supported by several factors. The rising demand for anti-aging products and therapies is one of the major factors propelling the NMN market. The demand for anti-aging goods is growing as individuals become more health-conscious and aware of the advantages of a healthy lifestyle. NMN has been discovered to be a potent anti-aging substance that can aid in slowing down aging and enhancing general health and well-being. As a result, there is now more demand for NMN supplements and goods.

  • ~18 million adults aged 50+ take NMN globally, propelled by studies showing 20–40% NAD⁺ uplift within two weeks, fuelling more interest in anti‑aging regimes
  • 75+ clinical trials on NMN are ongoing or completed, demonstrating robust scientific backing which boosts consumer trust and adoption

The Growing Prevalence Of Chronic Diseases Such As Diabetes, Cancer, And Cardiovascular Diseases Fuels the Market Growth

The rising incidence of chronic disorders, including diabetes, cancer, and cardiovascular diseases, is another important driver driving the NMN market. As NMN has been demonstrated to be effective in treating and preventing various diseases, the usage of NMN products and supplements as preventative tools has increased. The market is partly expanding due to the increasing acceptance of NMN as a cognitive enhancer. The demand for NMN supplements increases as people’s interest in memory and cognitive performance improves. In conclusion, several reasons, such as the rising demand for anti-aging goods, the prevalence of chronic illnesses, and the popularity of NMN as a cognitive enhancer, drive the market for nicotinamide mononucleotide (NMN). In the upcoming years, we may anticipate continuing market increase as more study is done on the advantages of NMN.

RESTRAINING FACTORS

High Cost And Lack Of Long-Term Studies On The Safety And Efficacy Of NMN Hinders the Market Growth

The potential of nicotinamide mononucleotide (NMN) as an anti-aging supplement has led to growth in the NMN industry in recent years. Yet, there are several deterrents that investors in this market must take into account. First, NMN’s high production costs prevent it from being sold to a larger market. In addition, the regulatory environment around NMN is complicated and constantly shifting, which may cause confusion and reluctance among prospective investors. The lack of long-term studies on the safety and effectiveness of NMN is another point to consider. This might make it challenging for investors to advertise and sell the supplement reliably. While difficult, these elements also offer a chance for those who can effectively manage them and establish themselves as market leaders in the NMN sector.

  • 17% drop in available NMN SKUs on U.S. platforms in Q1 2023 after North American regulators started reviewing its pharmaceutical classification—highlighting classification risks
  • Regulatory disparity: Japan and Australia treat NMN as a supplement, whereas U.S. and EU are still evaluating it as a drug, causing global supply-chain fragmentation

NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET REGIONAL INSIGHTS

North America to Dominate Market Due to Growing Demand For Anti-Aging Supplements And Treatments

Between 2024 and 2033, the nicotinamide mononucleotide (NMN) market will be dominated by U.S. Factors driving the market growth in this region include the growing demand for anti-aging supplements and treatments.

Additionally, the market is anticipated to experience the fastest growth in European and Asian countries (India, China, Japan, and South East Asia). The growing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases fuels market expansion.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

  • GeneHarbor invested US $50 million in 2023 to significantly expand production capacity in China .
  • Herbalmax allocated US $20 million towards digital marketing and AI customer targeting in North America and Europe

List of Top Nicotinamide Mononucleotide (NMN) Companies

  • GeneHarbor (China)
  • Herbalmax (India)
  • Genex Formulas (U.S.)
  • Shinkowa Pharmaceutical (Japan)
  • Maac10 Formulas (U.S.)
  • EffePharm (China)
  • Bontac (China)
  • CELFULL (U.S.)
  • Kingdomway (China)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.

Nicotinamide Mononucleotide (NMN) Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 0.33 Billion in 2024

Market Size Value By

US$ 0.79 Billion by 2033

Growth Rate

CAGR of 10% from 2025 to 2033

Forecast Period

2025-2033

Base Year

2024

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • Content below 98%
  • Content above 98%

By Application

  • Health Care Products
  • Cosmetics

FAQs